Enzyme Stabilizers For Point-Of-Care Market Report 2026

Enzyme Stabilizers For Point-Of-Care Market Overview

• Enzyme Stabilizers For Point-Of-Care market size has reached to $1.53 billion in 2025 • Expected to grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Growing Healthcare Infrastructure Investment Driving The Market Growth Due To Expansion And Modernization Of Medical Facilities • Market Trend: Advancements In Ambient-Stable Enzyme Technologies Accelerate Decentralized Molecular Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Enzyme Stabilizers For Point-Of-Care Market?

Enzyme stabilizers for point-of-care are chemical formulations that preserve the stability and activity of enzymes used in rapid diagnostic tests near patient care settings. They protect enzymes from degradation caused by temperature changes, moisture, and other environmental stresses. These formulations ensure consistent performance and reliable diagnostic results outside conventional laboratories. The main product types of enzyme stabilizers for point-of-care include lyophilized enzyme formulations, liquid enzyme stabilizer solutions, enzyme preservation tablets, pre-formulated enzyme kits, and other product types. Lyophilized enzyme formulations refer to dried enzyme preparations designed to enhance stability and extend shelf life under varying storage conditions. The formulations include liquid, lyophilized, and other formulations and are distributed through direct sales, distributors, online sales, and other distributional channels. The various applications involved are diagnostic devices, biosensors, rapid test kits, and other applications, and they are used by several end users such as diagnostic kit manufacturers, hospitals and clinics, home care settings, research laboratories, and other end users.

What Is The Enzyme Stabilizers For Point-Of-Care Market Growth Forecast?

The enzyme stabilizers for point-of-care market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing deployment of multi-assay enzyme kits, growing demand for portable diagnostic enzyme kits, rising adoption of protein-based stabilizer solutions, expansion of field testing and clinical enzyme kits, increasing focus on shelf-life extension and cold chain independent formulations. Major trends in the forecast period include rising demand for lyophilized enzyme formulations, increasing adoption of ready-to-use liquid stabilizer solutions, growing focus on room temperature stable enzyme kits, expansion of enzyme stabilization for rapid diagnostic devices, rising preference for multi-enzyme preservation tablets.

Global Enzyme Stabilizers For Point-Of-Care Market Segmentation

1) By Product Type: Lyophilized Enzyme Formulations, Liquid Enzyme Stabilizer Solutions, Enzyme Preservation Tablets, Pre-Formulated Enzyme Kits, Other Product Types 2) By Formulation: Liquid, Lyophilized, Other Formulations 3) By Distribution Channel: Direct Sales, Distributors, Online Sales, Other Distributional Channels 4) By Application: Diagnostic Devices, Biosensors, Rapid Test Kits, Other Applications 5) By End User: Diagnostic Kit Manufacturers, Hospitals And Clinics, Home Care Settings, Research Laboratories, Other End Users Subsegments: 1) By Lyophilized Enzyme Formulations: Freeze Dried Single Enzyme Preparations, Freeze Dried Multi Enzyme Preparations, Long Shelf Life Formulations, Room Temperature Stable Formulations, Cold Chain Stable Formulations 2) By Liquid Enzyme Stabilizer Solutions: Aqueous Stabilizer Solutions, Buffered Stabilizer Solutions, Glycerol Based Stabilizer Solutions, Protein Based Stabilizer Solutions, Ready To Use Stabilizer Solutions 3) By Enzyme Preservation Tablets: Rapid Dissolution Tablets, Controlled Release Tablets, Room Temperature Stable Tablets, Blister Packed Tablets, Multi Enzyme Preservation Tablets 4) By Pre-Formulated Enzyme Kits: Single Assay Enzyme Kits, Multi Assay Enzyme Kits, Portable Diagnostic Enzyme Kits, Field Testing Enzyme Kits, Clinical Testing Enzyme Kits 5) By Other Product Types: Enzyme Stabilizing Beads, Enzyme Stabilizing Films, Coated Enzyme Strips, Encapsulated Enzyme Particles, Immobilized Enzyme Matrices

What Is The Driver Of The Enzyme Stabilizers For Point-Of-Care Market?

The growing investment in healthcare infrastructure is expected to drive the growth of the enzyme stabilizers for point-of-care market over the forecast period. Healthcare infrastructure investment involves the allocation of public and private funds to build, upgrade, and modernize healthcare facilities, diagnostic laboratories, medical equipment, and supporting systems to improve the quality, efficiency, and accessibility of healthcare services. Such investments are increasing in response to aging populations, rising disease burdens, and the growing need for advanced and decentralized diagnostic technologies. Enzyme stabilizers are essential in these environments, as they preserve the activity and reliability of enzymes used in rapid diagnostic assays under varying storage and operating conditions, ensuring accurate and consistent on-site test results. For instance, in May 2023, according to the UK Department of Health and Social Care, the government confirmed that the New Hospital Programme would receive over $27.02 billion (£20 billion) in funding for hospital infrastructure. Therefore, the growing healthcare infrastructure investment is driving the growth of the enzyme stabilizers for point-of-care industry.

Key Players In The Global Enzyme Stabilizers For Point-Of-Care Market

Major companies operating in the enzyme stabilizers for point-of-care market are market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Merck KGaA, Becton Dickinson Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Novonesis Inc., QIAGEN N.V., Amano Enzyme Inc., Surmodics Inc., Arista Biologicals Inc., BBI Solutions Ltd., Sisco Research Laboratories Pvt. Ltd., Advanced Enzyme Technologies Ltd., Codexis Inc., Enzo Life Sciences Inc., Biocatalysts Ltd., Enzyme Solutions Inc., Creative Enzymes Inc.

Global Enzyme Stabilizers For Point-Of-Care Market Trends and Insights

Major companies operating in the Enzyme Stabilizers for Point-of-Care market are focusing on developing innovative solutions, such as controlled and consistent DNA fragmentation, to enhance assay reliability, reduce variability, simplify workflows, and enable rapid, decentralized molecular testing at the point of care. Controlled and consistent DNA fragmentation is the precise and reproducible breaking of DNA into defined fragment sizes using enzymatic or mechanical methods, ensuring uniformity for reliable downstream applications like sequencing or diagnostics. For instance, in February 2026, Meridian Bioscience, Inc., a U.S.-based life science and diagnostic raw materials company, launched its Lyophilized NGS Enzymatic DNA Fragmentation Kit, an ambient-temperature stable enzymatic reagent system designed to simplify next-generation sequencing workflows for point-of-care and decentralized testing by eliminating cold-chain storage, enabling precise time-controlled DNA fragmentation with consistent activity after long-term ambient storage, reducing handling complexities, and supporting a wide range of sequencing applications where stability and ease of use are critical.

What Are Latest Mergers And Acquisitions In The Enzyme Stabilizers For Point-Of-Care Market?

In January 2025, Medix Biochemica, a Finland-based healthcare technology company, acquired CANDOR Bioscience GmbH for an undisclosed amount. With this acquisition, Medix Biochemica aimed to strategically strengthen and broaden its portfolio of critical raw materials for the in vitro diagnostics (IVD) industry and enhance its support and technological capabilities for immunoassay developers worldwide. CANDOR Bioscience GmbH is a Germany based biotechnology company that specializes in providing various enzyme stabilizers that are utilized in the development and production of point-of-care (POC) and in vitro diagnostic (IVD) tests.

Regional Insights

North America was the largest region in the enzyme stabilizers for point-of-care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Enzyme Stabilizers For Point-Of-Care Market?

The enzyme stabilizers for point-of-care market consists of sales of enzyme preservation tablets, and pre-formulated enzyme kits, composite enzyme protectants, and protein-free stabilizers. Values in this market are “factory gate” values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services such as technical support, formulation customization, regulatory compliance assistance, and storage and handling guidance sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Enzyme Stabilizers For Point-Of-Care Market Report 2026?

The enzyme stabilizers for point-of-care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme stabilizers for point-of-care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.